Form 8-K - Current report:
SEC Accession No. 0001213900-23-053572
Filing Date
2023-06-30
Accepted
2023-06-30 16:40:55
Documents
20
Period of Report
2023-06-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181153-8k_cormedix.htm   iXBRL 8-K 46252
2 UNDERWRITING AGREEMENT DATED JUNE 28, 2023 ea181153ex1-1_cormedix.htm EX-1.1 227029
3 FORM OF PRE-FUNDED WARRANT ea181153ex4-1_cormedix.htm EX-4.1 89788
4 OPINION OF MORGAN, LEWIS & BOCKIUS LLP ea181153ex5-1_cormedix.htm EX-5.1 10217
5 PRESS RELEASE DATED JUNE 28, 2023 ANNOUNCING THE COMMENCEMENT OF THE OFFERING ea181153ex99-1_cormedix.htm EX-99.1 11430
6 PRESS RELEASE DATED JUNE 28, 2023 ANNOUNCING THE PRICING OF THE OFFERING ea181153ex99-2_cormedix.htm EX-99.2 15165
7 GRAPHIC ex99-1_001.jpg GRAPHIC 18675
8 GRAPHIC ex99-2_001.jpg GRAPHIC 18935
12 GRAPHIC image_001.jpg GRAPHIC 2960
  Complete submission text file 0001213900-23-053572.txt   724077

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE crmd-20230628.xsd EX-101.SCH 2959
10 XBRL LABEL FILE crmd-20230628_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE crmd-20230628_pre.xml EX-101.PRE 22359
14 EXTRACTED XBRL INSTANCE DOCUMENT ea181153-8k_cormedix_htm.xml XML 3591
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 231062341
SIC: 2834 Pharmaceutical Preparations